Janux Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
399
across all filing types
Latest filing
2026-04-28
Regulatory Filings
Country
US
United States of America
Listing
US
JANX
Janux Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies for cancer. The company utilizes its proprietary Tumor Activated T Cell Engager (TRACTr) platform to engineer therapeutics designed for conditional activation within the tumor microenvironment. This technology aims to create highly specific treatments that direct the immune system to attack cancer cells while minimizing systemic toxicity associated with conventional T cell engagers. Janux is advancing a pipeline of these precision-engineered therapies to address solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Janux Therapeutics, Inc. (0001817713) (Filer) | 2026-04-28 | English | |
| 10-K - JANUX THERAPEUTICS, INC. (0001817713) (Filer) | 2026-02-26 | English | |
| 8-K - JANUX THERAPEUTICS, INC. (0001817713) (Filer) | 2026-02-26 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G Filing | 2026-02-06 | English | |
| 4 Filing | 2026-02-04 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38179450 | 8-K - Janux Therapeutics, Inc. (0001817713) (Filer) | 2026-04-28 | English | ||
| 32898863 | 10-K - JANUX THERAPEUTICS, INC. (0001817713) (Filer) | 2026-02-26 | English | ||
| 32898862 | 8-K - JANUX THERAPEUTICS, INC. (0001817713) (Filer) | 2026-02-26 | English | ||
| 31851600 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31851579 | SCHEDULE 13G Filing | 2026-02-06 | English | ||
| 31851596 | 4 Filing | 2026-02-04 | English | ||
| 31851578 | 3 Filing | 2026-02-04 | English | ||
| 13271804 | 8-K | 2026-01-22 | English | ||
| 13271806 | Major Shareholding Notification 2026 | 2026-01-08 | English | ||
| 13271805 | Director's Dealing 2026 | 2026-01-03 | English | ||
| 13271807 | Director's Dealing 2026 | 2026-01-03 | English | ||
| 13271808 | Director's Dealing 2026 | 2026-01-03 | English | ||
| 13271809 | Director's Dealing 2026 | 2026-01-03 | English | ||
| 13271810 | Director's Dealing 2026 | 2026-01-03 | English | ||
| 13271811 | Director's Dealing 2026 | 2026-01-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Janux Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31963/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31963 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31963 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31963 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31963}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Janux Therapeutics, Inc. (id: 31963)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.